Novel Strategies for Reducing Burn Scar Itch

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Burn Scar, Itch Scarring, Wound

In brief

The purpose of the study is to see whether using diphenhydramine (Benadryl), famotidine (Pepcid), and cromolyn sodium will decrease burn scar itch.

Key facts

Study ID

NCT06801626

Run by

The University of Texas Medical Branch, Galveston

People needed

44

Starts

2025-03-01

Expected to finish

2027-11-01

Last updated by the study team

2025-09-24

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants must meet all the inclusion criteria in order to be eligible to participate in the study.
• Participant has provided informed consent in a manner approved by the IRB and is willing and able to comply with the trial procedures.
• Adults: ≥18 to <80 years of age.
• Has an itchy burn scar.

You may not qualify if…

• Participants meeting any of the exclusion criteria at baseline will be excluded from study participation.
• Failure to obtain consent or unable to return for follow up assessments.
• Patient is unable to follow the protocol required assessments.
• Member of a vulnerable class (e.g., prisoners, pregnant participant, etc.).
• Any medical condition that, in the opinion of the investigator or physician, would place the participant at increased risk for participation.
• Concurrent participation in another interventional clinical trial (to avoid confounding factors that may influence outcomes).
• History of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction) that would, in the opinion of the investigator, make it difficult for the participant to comply with the study procedures or follow the investigators instructions.
• Age < 18 or ≥ 80 years.
• Taking one of the following medications: cefuroxime, dasatinib, delavirdine, neratinib, pazopanib, risedronate, or tizanidine.
• Has a pre-existing inflammatory or itchy skin disease.
• Is taking an H2 antihistamine for another indication.

Where it is running

• University of Texas Medical Branch, Galveston — Galveston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.